Search results
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 4 hours agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 hours agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Novavax's Q1 Results Are Overshadowed by Its Sanofi Partnership | The Motley Fool
The Motley Fool· 5 hours agoNovavax (NVAX 46.12%) released its first-quarter earnings report on May 10, and the vaccine-focused biotechnology company's numbers reflected notable progress ...
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 10 hours agoJust when the Covid-vaccine maker Novavax Inc.'s (NVAX) future as a going concern seemed uncertain, a remarkable turnaround has unfolded, thanks to the ...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi By Investing.com
Investing.com· 22 hours agovaccine market leadership to commercialize its Nuvaxovid vaccine in the U.S., U.K., and Europe. ...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga via Yahoo Finance· 3 days agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
Will your last COVID vaccine work against new ‘FLiRT’ variants?
WJZY via Yahoo News· 1 day agoUltimately, it depends on when you got your last dose. In fall, an updated COVID vaccine was...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
WFRV 5 Green Bay· 4 days ago...Agreements and in India, Japan and South Korea where Novavax has existing partnership agreements); a sole license to Novavax's adjuvanted COVID-19 vaccine for use in combination with Sanofi's flu vaccines while Novavax retains the right to and is developing its own COVID-19-Influenza Combination ...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 3 days agoDriving the news: Novavax will receive an upfront payment of $500 million and up to $700 million in...